Cochlear disagrees with new competition concerns over takeover
Hearing implant manufacturer Cochlear has again rebuffed competition concerns from authorities over its planned takeover of competitor Oticon Medical for $170 million, which followed a decision by parent company Demant to exit the hearing implants business. Cochlear said it disagreed with the conclusions of the UK Competition and Markets Authority (CMA) which found provisionally that…